Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18316-18329
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18316
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18316
Figure 2 Representative flow plots and levels of CD4+ T and CD4+IL-17A+ T cells in mesenteric lymph nodes from normal mice fed high dose Bifidobacterium infantis.
A: Levels of mesenteric lymph node (MLN) CD4+T cells in PBS-control and Bifidobacterium infantis (B. infantis) treated groups; B: Levels of CD4+IL-17A+T cells in PBS-control and B. infantis treated groups; C: The percentage of MLN CD4+T cells; D: The percentage of CD4+IL-17A+T cells. Results are either shown as mean ± SE from three independent experiments, n = 5 (bar graphs) or as a representative flow cytometry graph.
-
Citation: Zuo L, Yuan KT, Yu L, Meng QH, Chung PCK, Yang DH.
Bifidobacterium infantis attenuates colitis by regulating T cell subset responses. World J Gastroenterol 2014; 20(48): 18316-18329 - URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18316.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18316